Certara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent Toolkit
Certara has partnered with NVIDIA to integrate the BioNeMo Agent Toolkit into its open integrated AI platform for drug development. The collaboration aims to unify Certara’s scientific software, regulatory expertise, and proprietary datasets with NVIDIA’s AI-first agentic frameworks to accelerate insight generation.
Key figures
- Client count
- 2600
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.